We have launched a panel of 20 genes to test for Osteogenesis Imperfecta and a panel of 3 genes for Frazer Syndrome testing. Find more at www.asperbio.com/asper-dysmorphology
List of diseases covered by Osteogenesis Imperfecta NGS panel
Published 12/12/2018List of diseases covered by
Osteogenesis Imperfecta NGS panel
| Gene | Condition |
| ALPL | Hypophosphatasia, adult; Hypophosphatasia, childhood; Hypophosphatasia, infantile |
| ANO5 | Gnathodiaphyseal dysplasia; Miyoshi muscular dystrophy 3; Muscular dystrophy, limb-girdle, autosomal recessive 12 |
| BMP1 | Osteogenesis imperfecta, type XIII |
| CA2 | Osteopetrosis, autosomal recessive 3, with renal tubular acidosis |
| CLCN7 | Hypopigmentation, organomegaly, and delayed myelination and development; Osteopetrosis, autosomal dominant 2; Osteopetrosis, autosomal recessive 4 |
| COL1A1 | Caffey disease; Ehlers-Danlos syndrome, arthrochalasia type, 1; Osteogenesis imperfecta, type I; Osteogenesis imperfecta, type Ii; Osteogenesis imperfecta, type III; Osteogenesis imperfecta, type IV |
| COL1A2 | hlers-Danlos syndrome, arthrochalasia type, 2; Ehlers-Danlos syndrome, cardiac valvular type; Osteogenesis imperfecta, type II; Osteogenesis imperfecta, type III; Osteogenesis imperfecta, type IV |
| CREB3L1 | Osteogenesis imperfecta, type XVI |
| CRTAP | Osteogenesis imperfecta, type VII |
| CTSK | Pycnodysostosis |
| DSPP | Deafness, autosomal dominant 39, with dentinogenesis; Dentin dysplasia, type II; Dentinogenesis imperfecta, Shields type II; Dentinogenesis imperfecta, Shields type III |
| FGFR3 | CATSHL syndrome; Achondroplasia; Crouzon syndrome with acanthosis nigricans; Hypochondroplasia; LADD syndrome; Muenke syndrome; SADDAN; Thanatophoric dysplasia, type I; Thanatophoric dysplasia, type II |
| FKBP10 | Osteogenesis imperfecta, type XI; Bruck syndrome 1 |
| GORAB | Geroderma osteodysplasticum |
| IFITM5 | Osteogenesis imperfecta, type V |
| KDELR2 | Osteogenesis imperfecta |
| LRP5 | Exudative vitreoretinopathy 4; Hyperostosis, endosteal; Osteopetrosis, autosomal dominant 1; Osteoporosis-pseudoglioma syndrome; Polycystic liver disease 4 with or without kidney cysts; van Buchem disease, type 2 |
| MBTPS2 | Osteogenesis imperfecta, type XIX; Olmsted syndrome, X-linked; IFAP syndrome with or without BRESHECK syndrome; Keratosis follicularis spinulosa decalvans, X-linked |
| MESD | Osteogenesis imperfecta, type XX |
| NOTCH2 | Alagille syndrome 2; Hajdu-Cheney syndrome |
| OSTM1 | Osteopetrosis, autosomal recessive 5 |
| P3H1 | Osteogenesis imperfecta, type VIII |
| P4HB | Cole-Carpenter syndrome 1 |
| PLEKHM1 | Osteopetrosis, autosomal recessive 6; Osteopetrosis, autosomal dominant 3 |
| PLOD2 | Bruck syndrome 2 |
| PLS3 | Bone mineral density QTL18, osteoporosis |
| PPIB | Osteogenesis imperfecta, type IX |
| SEC24D | Cole-Carpenter syndrome 2 |
| SERPINF1 | Osteogenesis imperfecta, type VI |
| SERPINH1 | Osteogenesis imperfecta, type X |
| SLC26A2 | Achondrogenesis Ib; Atelosteogenesis, type II; De la Chapelle dysplasia; Diastrophic dysplasia; Epiphyseal dysplasia, multiple, 4 |
| SNX10 | Osteopetrosis, autosomal recessive 8 |
| SOX9 | Acampomelic campomelic dysplasia; Campomelic dysplasia; Campomelic dysplasia with autosomal sex reversal |
| SP7 | Osteogenesis imperfecta, type XII |
| SPARC | Osteogenesis imperfecta, type XVII |
| TCIRG1 | Osteopetrosis, autosomal recessive 1 |
| TENT5A | Osteogenesis imperfecta, type XVIII |
| TMEM38B | Osteogenesis imperfecta, type XIV |
| TNFRSF11A | Osteopetrosis, autosomal recessive 7 |
| TNFSF11 | Osteopetrosis, autosomal recessive 2 |
| WNT1 | Osteogenesis imperfecta, type XV |
Osteogenesis Imperfecta NGS panel
Published 12/12/2018Osteogenesis Imperfecta NGS panel
| Genes (full coding region): |
ALPL, ANO5, BMP1, CA2, CLCN7, COL1A1, COL1A2, CREB3L1, CRTAP, CTSK, DSPP, FGFR3, FKBP10, GORAB, IFITM5, KDELR2, LRP5, MBTPS2, MESD, NOTCH2, OSTM1, P3H1, P4HB, PLEKHM1, PLOD2, PLS3, PPIB, SEC24D, SERPINF1, SERPINH1, SLC26A2, SNX10, SOX9, SP7, SPARC, TCIRG1, TENT5A, TMEM38B, TNFRSF11A, TNFSF11, WNT1 |
| Lab method: | NGS panel with CNV analysis |
| TAT: | 6-9 weeks |
| Specimen requirements: | 2-4 ml of blood with anticoagulant EDTA
1 µg DNA in TE, AE or pure sterile water at 100-250 ng/µl |
| Ordering information: | Go to online ordering or download sample submission form |

